Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates

Infection Control and Hospital Epidemiology

Volumn 29, Issue 10, 2008, Pages 993-994

  Mongkolrattanothai, Kanokporn ^a   Mankin, Peggy ^a   Raju, Venkedesh ^a   Gray, Barry ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; PSEUDOMONIC ACID;

ANTIBIOTIC RESISTANCE; BACTERIUM CARRIER; BACTERIUM ISOLATE; CLINICAL PRACTICE; DRUG SENSITIVITY; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SURVEY; HYGIENE; INFECTION CONTROL; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; POLYMERASE CHAIN REACTION;

ANTI-BACTERIAL AGENTS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN RESISTANCE; MUPIROCIN; PREVALENCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 53549093283     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/590536     Document Type: Letter

References (10)

1. Hughes J, Mellows G. Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J 1978; 176:305-318.
2. Vasquez JE, Walker ES, Franzus BW, Overbay BK, Reagan DR, Sarubbi FA. The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans' Affairs hospital. Infect Control Hosp Epidemiol 2000; 21:459-464.
3. Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007; 45:541-547.
4. Zhang K, Sparling J, Chow BL, et al. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J Clin Microbiol 2004; 42:4947-4955.
5. Finlay JE, Miller LA, Poupard JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 1997; 41:1137-1139.
6. Creagh S, Lucey B. Interpretive criteria for mupirocin susceptibility testing of Staphylococcus spp. using CLSI guidelines. Br J Biomed Sci 2007; 64:1-5.
7. Andrews JM; BSAC Working Party on Susceptibility Testing. BSAC standardized disc susceptibility testing method (version 6). J Antimicrob Chemother 2007; 60:20-41.
8. Palepou MF, Johnson AP, Cookson BD, Beattie H, Charlett A, Woodford N. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrob Chemother 1998; 42:577-583.
9. de Oliveira NE, Cardozo AP, Marques Ede A, dos Santos KR, Giambiagi-deMarval M. Interpretive criteria to differentiate low- and high-level mupirocin resistance in Staphylococcus aureus. J Med Microbiol 2007; 56:937-939.
10. Deshpande LM, Fix AM, Pfaller MA, Jones RN; SENTRY Antimicrobial Surveillance Program Participants Group. Emerging elevated mupirocin resistance rates among staphylococcal isolates in the SENTRY Antimicrobial Surveillance Program (2000): correlations of results from disk diffusion, Etest and reference dilution methods. Diagn Microbiol Infect Dis 2002; 42:283-290.